Theralase Technologies (TSE:TLT)
TSXV:TLT
Holding TSE:TLT?
Track your performance easily

Theralase Technologies (TLT) Financial Statements

78 Followers

Theralase Technologies Financial Overview

Theralase Technologies's market cap is currently ―. The company's EPS TTM is C$-0.019; its P/E ratio is -9.54; Theralase Technologies is scheduled to report earnings on November 28, 2024, and the estimated EPS forecast is C
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-C$ 280.61KC$ 218.93KC$ 207.16KC$ 325.57K
Gross Profit-C$ 141.67KC$ 108.62KC$ 92.52KC$ 204.41K
EBIT-C$ -1.01MC$ -1.15MC$ -1.40MC$ -874.33K
EBITDA-C$ -936.39KC$ -1.08MC$ -1.33MC$ -795.45K
Net Income Common Stockholders-C$ -1.02MC$ -1.16MC$ -1.41MC$ -883.20K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 317.55KC$ 482.46KC$ 603.69KC$ 533.47KC$ 1.65M
Total AssetsC$ 3.28MC$ 3.00MC$ 3.38MC$ 3.20MC$ 4.16M
Total DebtC$ 386.88KC$ 409.14KC$ 431.01KC$ 452.50KC$ 473.62K
Net DebtC$ 69.33KC$ -73.33KC$ -172.68KC$ -80.97KC$ -1.18M
Total LiabilitiesC$ 1.37MC$ 1.37MC$ 1.34MC$ 1.35MC$ 1.07M
Stockholders EquityC$ 1.91MC$ 1.63MC$ 2.04MC$ 1.85MC$ 3.09M
Cash Flow-
Free Cash Flow-C$ -605.33KC$ -1.13MC$ -1.12MC$ -1.17M
Operating Cash FlowC$ -1.25MC$ -594.42KC$ -1.12MC$ -1.11MC$ -1.10M
Investing Cash FlowC$ -11.44KC$ -10.91KC$ -3.05KC$ -11.87KC$ -63.32K
Financing Cash FlowC$ 1.07MC$ 433.12KC$ 1.17MC$ -21.87KC$ 226.28K
Currency in CAD

Theralase Technologies Earnings and Revenue History

Theralase Technologies Debt to Assets

Theralase Technologies Cash Flow

Theralase Technologies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis